生物保存市場規模、佔有率和成長分析（按產品、生物樣本、應用、最終用戶和地區）- 產業預測 2025-2032

2023 年全球生物保存市場規模為 28 億美元，預計將從 2024 年的 35.9 億美元成長到 2032 年的 263.8 億美元，預測期內（2025-2032 年）的複合年成長率為 28.3%。

由於技術進步以及對生質能和生物產品（包括 DNA、組織和幹細胞）保存的需求不斷增加，生物保存市場正在經歷顯著成長。微陣列和預測模型整合等最新技術創新正在簡化生物保存過程，減少時間、成本和複雜性。此外，連接複用細胞成像平台正在增強生物保存能力並促進其在心臟病學和婦科等專業的應用。隨著慢性病的增加，人們對開發免疫療法和疫苗等生物解決方案的興趣日益濃厚，進一步推動了對生物保存的需求。此外，公私合作也有助於資助研發計劃，而醫療保健支出的增加預計將在未來幾年推動市場持續擴張。

目錄

介紹

• 調查目的
• 研究範圍
• 定義

調查方法

• 資訊採購
• 次要和主要資料方法
• 市場規模預測
• 市場假設與限制

執行摘要

• 全球市場展望
• 供需趨勢分析
• 細分機會分析

市場動態及展望

• 市場概況
• 市場規模
• 市場動態
  • 促進因素和機會
  • 限制與挑戰
• 波特的分析

主要市場考察

• 關鍵成功因素
• 競爭程度
• 主要投資機會
• 市場生態系統
• 市場吸引力指數（2024 年）
• PESTEL 分析
• 總體經濟指標
• 價值鏈分析
• 定價分析
• 監管分析
• 技術分析

生物保存市場規模（按產品）

• 市場概況
• 生物保存介質
  • 冷凍保存介質
  • 冷凍保存介質
• 生物保鮮設備
  • 溫度控制系統
  • 冷凍庫
  • 低溫儲存系統
  • 除霜裝置
  • 冰箱
  • 警報及監控系統
  • 培養箱
  • 離心機
  • 其他生物保鮮設備
• 生物保存配件

生物保存市場規模（依生物樣本）

• 市場概況
• 人體組織樣本
• 器官
• 幹細胞
• 其他生物標本

生物保存市場規模（按應用）

• 市場概況
• 研究用途
• 治療用途
• 其他用途

生物保存市場規模（按最終用戶分類）

• 市場概況
• 生物庫
• 基因庫
• 醫院
• 其他最終用戶

生物保存市場規模

• 北美洲
  • 美國
  • 加拿大
• 歐洲
  • 德國
  • 西班牙
  • 法國
  • 英國
  • 義大利
  • 其他歐洲國家地區
• 亞太地區
  • 中國
  • 印度
  • 日本
  • 韓國
  • 其他亞太地區
• 拉丁美洲
  • 巴西
  • 其他拉丁美洲國家
• 中東和非洲
  • 海灣合作理事會國家
  • 南非
  • 其他中東和非洲地區

競爭資訊

• 前 5 家公司對比
• 主要企業市場定位（2024年）
• 主要市場參與者所採用的策略
• 近期市場趨勢
• 公司市場佔有率分析（2024 年）
• 主要企業簡介
  • 公司詳細資訊
  • 產品系列分析
  • 公司分部佔有率分析
  • 收益與前一年同期比較對比（2022-2024 年）

主要企業簡介

• Thermo Fisher Scientific Inc.（United States）
• Merck KGaA（Germany）
• BioLife Solutions, Inc.（United States）
• STEMCELL Technologies（Canada）
• Helmer Scientific Inc.（United States）
• PrincetonCryo（United States）
• OPS Diagnostics（United States）
• ThermoGenesis Holdings, Inc.（United States）
• Avantor, Inc.（United States）
• Bio-Techne Corporation（United States）
• Exact Sciences Corporation（United States）
• Worthington Industries, Inc.（United States）
• Chart Industries, Inc.（United States）
• Azenta US, Inc.（United States）
• LabVantage Solutions, Inc.（United States）
• Qiagen NV（Netherlands）
• Taylor-Wharton Cryogenics LLC（United States）
• PHC Holdings Corporation（Japan）
• Panasonic Corporation（Japan）
• Lifeline Scientific, Inc.（United States）

結論和建議

Global Biopreservation Market size was valued at USD 2.8 billion in 2023 and is poised to grow from USD 3.59 billion in 2024 to USD 26.38 billion by 2032, growing at a CAGR of 28.3% during the forecast period (2025-2032).

The biopreservation market is experiencing notable growth, driven by advancements in technology and an increasing demand for the preservation of biomass and biological products, including DNA, tissues, and stem cells. Recent innovations, such as microarrays and predictive modeling integration, have streamlined the biopreservation process, reducing time, costs, and complexity. Additionally, multiplex cellular imaging platforms enhance biopreservation capabilities, fostering adoption in specialties like cardiology and gynecology. With a rise in chronic diseases, there's heightened interest in developing biological solutions such as immunotherapies and vaccines, further propelling biopreservation demand. Collaborations between public and private sectors are also boosting funding for R&D initiatives, while growing healthcare expenditures are expected to drive continued market expansion in the coming years.

Top-down and bottom-up approaches were used to estimate and validate the size of the Global Biopreservation market and to estimate the size of various other dependent submarkets. The research methodology used to estimate the market size includes the following details: The key players in the market were identified through secondary research, and their market shares in the respective regions were determined through primary and secondary research. This entire procedure includes the study of the annual and financial reports of the top market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares split, and breakdowns were determined using secondary sources and verified through Primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data.

Global Biopreservation Market Segments Analysis

Global Biopreservation Market is segmented by Product, Biospecimen, Application, End User and region. Based on Product, the market is segmented into Biopreservation Media, Biopreservation Equipment and Biopreservation Accessories. Based on Biospecimen, the market is segmented into Human Tissue Samples, Organs, Stem Cells and Other Biospecimens. Based on Application, the market is segmented into Research Applications, Therapeutic Applications, Other Applications. Based on End User, the market is segmented into Biobanks, Gene Banks, Hospitals and Other End Users. Based on region, the market is segmented into North America, Europe, Asia Pacific, Latin America and Middle East & Africa.

Driver of the Global Biopreservation Market

The Global Biopreservation market is significantly driven by the increasing prevalence of chronic diseases worldwide. In developed nations like the United States, over 30% of adults are reported to be affected by these conditions annually, while in developing countries such as India, the figure exceeds 23%. The growing number of chronic disease cases necessitates enhanced diagnostic methods and alternative therapies, which consequently heightens the demand for biopreservation solutions. As healthcare systems strive to manage these diseases effectively, the need for innovative biopreservation techniques to safeguard biological materials becomes essential, further propelling the growth of this market.

Restraints in the Global Biopreservation Market

The Global Biopreservation market faces several restraints primarily revolving around the management of vital environmental factors such as temperature, pressure, and pH, essential for maintaining biomass stability during storage. Achieving effective biopreservation necessitates the use of advanced equipment, specialized consumables, media solutions, and trained personnel, all of which can contribute to elevated costs. Moreover, certain consumables exhibit significant instability and are not readily accessible in the market, further complicating the situation. The substantial initial investment required for setting up biopreservation infrastructure poses a barrier to broader applications across various sectors, limiting the market's overall expansion and accessibility.

Market Trends of the Global Biopreservation Market

The Global Biopreservation market is poised for significant growth, driven by the escalating demand for cell therapy and genetic engineering, anticipated to surge at over 30% CAGR during the forecast period. This trend is catalyzing increased investments from biomedical firms in research and development, as innovative cell and gene therapies revolutionize the diagnosis and treatment of severe and chronic health conditions. Additionally, rising government funding for research centers dedicated to gene therapy and regenerative medicine underscores a robust commitment to advancing these technologies. This confluence of factors positions the biopreservation sector as a crucial player in the future of healthcare.

Table of Contents

Introduction

• Objectives of the Study
• Scope of the Report
• Definitions

Research Methodology

• Information Procurement
• Secondary & Primary Data Methods
• Market Size Estimation
• Market Assumptions & Limitations

Executive Summary

• Global Market Outlook
• Supply & Demand Trend Analysis
• Segmental Opportunity Analysis

Market Dynamics & Outlook

• Market Overview
• Market Size
• Market Dynamics
  • Drivers & Opportunities
  • Restraints & Challenges
• Porters Analysis
  • Competitive rivalry
  • Threat of substitute
  • Bargaining power of buyers
  • Threat of new entrants
  • Bargaining power of suppliers

Key Market Insights

• Key Success Factors
• Degree of Competition
• Top Investment Pockets
• Market Ecosystem
• Market Attractiveness Index, 2024
• PESTEL Analysis
• Macro-Economic Indicators
• Value Chain Analysis
• Pricing Analysis
• Regulatory Analysis
• Technology Analysis

Global Biopreservation Market Size by Product & CAGR (2025-2032)

• Market Overview
• Biopreservation Media
  • Cryopreservation Media
  • Hypothermic Preservation Media
• Biopreservation Equipment
  • Temperature Control Systems
  • Freezers
  • Cryogenic Storage Systems
  • Thawing Equipment
  • Refrigerators
  • Alarm Monitoring Systems
  • Incubators
  • Centrifuges
  • Other Biopreservation Equipment
• Biopreservation Accessories

Global Biopreservation Market Size by Biospecimen & CAGR (2025-2032)

• Market Overview
• Human Tissue Samples
• Organs
• Stem Cells
• Other Biospecimens

Global Biopreservation Market Size by Application & CAGR (2025-2032)

• Market Overview
• Research Applications
• Therapeutic Applications
• Other Applications

Global Biopreservation Market Size by End User & CAGR (2025-2032)

• Market Overview
• Biobanks
• Gene Banks
• Hospitals
• Other End Users

Global Biopreservation Market Size & CAGR (2025-2032)

• North America (Product, Biospecimen, Application, End User)
  • US
  • Canada
• Europe (Product, Biospecimen, Application, End User)
  • Germany
  • Spain
  • France
  • UK
  • Italy
  • Rest of Europe
• Asia Pacific (Product, Biospecimen, Application, End User)
  • China
  • India
  • Japan
  • South Korea
  • Rest of Asia-Pacific
• Latin America (Product, Biospecimen, Application, End User)
  • Brazil
  • Rest of Latin America
• Middle East & Africa (Product, Biospecimen, Application, End User)
  • GCC Countries
  • South Africa
  • Rest of Middle East & Africa

Competitive Intelligence

• Top 5 Player Comparison
• Market Positioning of Key Players, 2024
• Strategies Adopted by Key Market Players
• Recent Developments in the Market
• Company Market Share Analysis, 2024
• Company Profiles of All Key Players
  • Company Details
  • Product Portfolio Analysis
  • Company's Segmental Share Analysis
  • Revenue Y-O-Y Comparison (2022-2024)

Key Company Profiles

• Thermo Fisher Scientific Inc. (United States)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Merck KGaA (Germany)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• BioLife Solutions, Inc. (United States)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• STEMCELL Technologies (Canada)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Helmer Scientific Inc. (United States)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• PrincetonCryo (United States)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• OPS Diagnostics (United States)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• ThermoGenesis Holdings, Inc. (United States)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Avantor, Inc. (United States)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Bio-Techne Corporation (United States)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Exact Sciences Corporation (United States)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Worthington Industries, Inc. (United States)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Chart Industries, Inc. (United States)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Azenta US, Inc. (United States)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• LabVantage Solutions, Inc. (United States)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Qiagen N.V. (Netherlands)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Taylor-Wharton Cryogenics LLC (United States)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• PHC Holdings Corporation (Japan)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Panasonic Corporation (Japan)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Lifeline Scientific, Inc. (United States)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments

Conclusion & Recommendations